Implantable Rechargeable SCS Project Receives Funding from National Key R & D Program

Implantable Rechargeable Spinal Cord Stimulator Project Receives

 Funding from National Key R & D Program

Changzhou Rishena Medical device Co., Ltd., as the lead unit, cooperated with Tsinghua University, the Institute of Semiconductors of the Chinese Academy of Sciences, Xuanwu Hospital of Capital Medical University, Beijing University People's Hospital, and Beijing Beiqi Medical, has received funding and support from the key R & D plan of the Ministry of Science and Technology, with support funds of 10 million yuan.

Project Name: Research on the key technologies and clinical applications of neural regulation and intelligent rehabilitation of Alzheimer's disease.

There are more than 10 million patients with intractable pain in China. Drugs and surgery often fail to achieve therapeutic effects. Implantable spinal cord stimulators can be used to treat refractory lumbar and leg pain, back surgery failure syndrome, and complex local pain syndrome. Limb pain, ischemic pain, etc. At present, the imported products on the market are expensive and the treatment is simple. The implementation of this project can bring the products to the market as soon as possible and replace imports. At the same time, new functions can more adapt to the requirements of Chinese patients and improve the efficacy.

In addition to the treatment of chronic pain, implantable spinal cord stimulators are also effective in the recovery of spinal cord injury, peripheral vascular occlusive diseases of the limbs, and have been tried for the treatment of restless leg syndrome. With the continuous development of technology and verification of clinical experiments, it shows that spinal cord nerve stimulation has broad application prospects.